sonar-pro
Targets an average marketing authorization (MA) approval timeline of six months or less for pharmaceutical products.
{
  "id": "c9154e5e-fdec-4cbd-bb96-d42c6cec48d1",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"status\":\"UNKNOWN\",\"explanation\":\"There is no explicit evidence in current search results indicating that the Philippines targets an average marketing authorization approval timeline of six months or less for pharmaceutical products.\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755750224,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 38,
    "prompt_tokens": 23,
    "total_tokens": 61,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.001,
      "request_cost": 0.006,
      "total_cost": 0.007
    }
  },
  "citations": [
    "https://pharmexcil.com/uploads/countryreports/Philippines.pdf",
    "https://pmc.ncbi.nlm.nih.gov/articles/PMC7516132/",
    "https://cruzmarcelo.com/philippine-department-of-health-issues-guidelines-for-the-registration-of-pharmaceutical-products-and-active-pharmaceutical-ingredients-intended-for-human-use/",
    "https://www.ijdra.com/index.php/journal/article/download/244/137",
    "https://pmc.ncbi.nlm.nih.gov/articles/PMC9734413/"
  ],
  "search_results": [
    {
      "title": "[PDF] REGULATORY & MARKET PROFILE OF PHILIPPINES - Pharmexcil",
      "url": "https://pharmexcil.com/uploads/countryreports/Philippines.pdf",
      "date": null,
      "last_updated": "2025-03-27"
    },
    {
      "title": "Alignment in post-approval changes (PAC) guidelines in emerging ...",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7516132/",
      "date": "2020-08-25",
      "last_updated": "2025-06-01"
    },
    {
      "title": "Philippine Department of Health Issues Guidelines for the ...",
      "url": "https://cruzmarcelo.com/philippine-department-of-health-issues-guidelines-for-the-registration-of-pharmaceutical-products-and-active-pharmaceutical-ingredients-intended-for-human-use/",
      "date": "2025-02-04",
      "last_updated": "2025-02-08"
    },
    {
      "title": "[PDF] General requirements for marketing authorization transfers in ...",
      "url": "https://www.ijdra.com/index.php/journal/article/download/244/137",
      "date": "2018-06-15",
      "last_updated": "2024-11-06"
    },
    {
      "title": "Regulatory Pathways Supporting Expedited Drug Development and ...",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9734413/",
      "date": "2022-12-03",
      "last_updated": "2025-05-26"
    }
  ]
}